A new microfluidic device may help realize the potential of tumor-derived extracellular vesicles -- tiny lipid particles that carry molecules through the bloodstream -- as biomarkers that could monitor a tumor's response to therapy and provide detailed information to guide treatment choice.
from Top Health News -- ScienceDaily http://ift.tt/2EWyvEW
No comments:
Post a Comment